Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000180689 | SCV000233168 | benign | not specified | 2015-05-22 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000989217 | SCV001113735 | benign | L-2-hydroxyglutaric aciduria | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000989217 | SCV001139446 | benign | L-2-hydroxyglutaric aciduria | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000966416 | SCV001144392 | benign | not provided | 2018-09-14 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000180689 | SCV002067620 | likely benign | not specified | 2019-07-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000966416 | SCV004134092 | benign | not provided | 2023-03-01 | criteria provided, single submitter | clinical testing | L2HGDH: BS1, BS2 |
Prevention |
RCV003937644 | SCV004748893 | benign | L2HGDH-related condition | 2020-01-13 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |